Tacrolimus-Related Thrombotic Microangiopathy Following Simultaneous Kidney-Pancreas Transplant Complicated by Antibody Mediated Rejection

被引：0
作者：
Zhang, L. [1 ]
Kalthia, A. [1 ]
Carpenter, P. M. [1 ]
Weng, R. R. [1 ]
Foster, C. E. [1 ]
Tran, M. [1 ]
机构：
[1] UC Irvine Med Ctr, Orange, CA USA
来源：
TRANSFUSION | 2010年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：85A / 85A
页数：1
相关论文
共 50 条
  • [21] Impact of acute rejection episodes on long-term graft survival following simultaneous kidney-pancreas transplantation
    Reddy, KS
    Davies, D
    Ormond, D
    Tuteja, S
    Lucas, BA
    Johnston, TD
    Waid, T
    McKeown, JW
    Ranjan, D
    AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (04) : 439 - 444
  • [22] Impact of Bortezomib On the Treatment of Antibody Mediated Rejection Following Kidney Transplant.
    Kassis, Y.
    Shetty, A.
    Flechner, S.
    Chiesa-Vottero, A.
    Fatica, R.
    TRANSPLANTATION, 2014, 98 : 512 - 512
  • [23] Impact of Bortezomib On the Treatment of Antibody Mediated Rejection Following Kidney Transplant.
    Kassis, Y.
    Shetty, A.
    Flechner, S.
    Chiesa-Vottero, A.
    Fatica, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 512 - 512
  • [24] The inferior impact of antibody-mediated rejection on the clinical outcome of kidney allografts that develop de novo thrombotic microangiopathy
    Wu, Kaiyin
    Budde, Klemens
    Schmidt, Danilo
    Neumayer, Hans-Hellmut
    Lehner, Lukas
    Bamoulid, Jamal
    Rudolph, Birgit
    CLINICAL TRANSPLANTATION, 2016, 30 (02) : 105 - 117
  • [25] Development of immune response to tissue-restricted self-antigens in simultaneous kidney-pancreas transplant recipients with acute rejection
    Gunasekaran, Muthukumar
    Vachharajani, Neeta
    Gaut, Joseph P.
    Maw, Thin Thin
    Delos Santos, Rowena
    Shenoy, Surendra
    Chapman, William C.
    Wellen, Jason
    Mohanakumar, Thalachallour
    CLINICAL TRANSPLANTATION, 2017, 31 (08)
  • [26] DEVELOPMENT OF IMMUNE RESPONSES TO TISSUE-RESTRICTED SELF-ANTIGENS IN SIMULTANEOUS KIDNEY-PANCREAS TRANSPLANT RECIPIENTS WITH ACUTE REJECTION
    Gunasekaran, Muthukumar
    Vachharajani, Neeta
    Gaut, Joseph
    Phelan, Donna
    Maw, Thin Thin
    Delos Santos, Rowena
    Shenoy, Surendra
    Chapman, William
    Wellen, Jason
    Mohanakumar, Thalachallour
    HUMAN IMMUNOLOGY, 2016, 77 : 79 - 79
  • [27] SHOULD UREMIC DIABETIC-PATIENTS WHO WANT A PANCREAS TRANSPLANT RECEIVE A SIMULTANEOUS CADAVER KIDNEY-PANCREAS TRANSPLANT OR A LIVING RELATED DONOR KIDNEY 1ST FOLLOWED BY CADAVER PANCREAS TRANSPLANT
    CHEUNG, AHS
    MATAS, AJ
    GRUESSNER, RG
    DUNN, DL
    MOUDRYMUNNS, KC
    NAJARIAN, JS
    SUTHERLAND, DER
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 1184 - 1185
  • [28] Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation
    Lo, A
    Stratta, RJ
    Alloway, RR
    Egidi, MF
    Shokouh-Amiri, MH
    Grewal, HP
    Gaber, AO
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1701 - 1703
  • [29] A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis
    Stratta, RJ
    Alloway, RR
    Hodge, E
    Lo, A
    CLINICAL TRANSPLANTATION, 2002, 16 (01) : 60 - 68
  • [30] Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation.
    Lo, A
    Stratta, RJ
    Alloway, RR
    Egidi, FM
    Shokouh-Amiri, H
    Grewal, HP
    Kizilisik, TA
    Gaber, AO
    TRANSPLANTATION, 2000, 69 (08) : S210 - S210
12345